Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation.
Leukemia (2015)
  • Roland B. Walter, University of Washington
  • Boglarka Gyurkocza, University of Washington
  • Barry E. Storer, Fred Hutchinson Cancer Research Center
  • Colin D. Godwin, University of Washington
  • John M. Pagel, University of Washington
  • Sarah A. Buckley, University of Washington
  • Mohamed L. Sorror, University of Washington
  • Brent L. Wood, University of Washington
  • Rainer Storb, University of Washington
  • Frederick R. Appelbaum, University of Washington
  • Brenda M. Sandmaier, University of Washington
Link
Disciplines
Publication Date
January 1, 2015
DOI
10.1038/leu.2014.173
Citation Information
Roland B. Walter, Boglarka Gyurkocza, Barry E. Storer, Colin D. Godwin, et al.. "Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation." Leukemia Vol. 29 Iss. 1 (2015) p. 137 - 144
Available at: http://works.bepress.com/john-pagel/83/